Pharmacovigilance – News and Features
News
Value of TaqMan® Drug Metabolism Genotyping Assays Validated
Scientists from Applied Biosystems presented data demonstrating the accuracy of TaqMan® Drug Metabolism Genotyping Assays in identifying variation in genes that code for drug metabolism enzymes.
News
Cenix, Applied Biosystems and Dresden University Announce Collaboration
Collaboration to create facility for proteomics profiling of RNAi and drug effects in human cells.
News
Study Emphasizes the Importance of Metabolomics to the Advent of Personalized Medicine
The emergence of genomics and proteomics technologies has opened the door for the application of metabolic profiling.
News
Calando Pharmaceuticals Lead siRNA Anti-Cancer Therapeutic Candidate Shown to be well Tolerated in Non-Human Primate Safety Study
Calando Pharmaceuticals has announced results of a pilot safety-study using Calandos lead siRNA therapeutic candidate in non-human primates.
News
Osmetech Licenses Pharmacogenetic Marker for P450-CYP2D6 from Epidauros
The agreement covers the genetic variant 2988G>A in the CYP2D6 gene.
News
Microarray Technology Goes Beyond the Genome
Diagnostics and Therapeutics are the new beneficiaries of microarray technology.
News
Morphotek Raises $40 Million to Advance Its Antibody Pipeline
The funds will be used primarily to further clinical development of the Company's lead therapeutic antibodies.
News
Genomic Tests Guide Choice of Chemotherapy in Cancer Patients
The tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy.
News
Stem Cells can Reduce the Side Effects of Radiation Therapy
Stem cells that settle in the organ systems could be stimulated and then repair tissue damage.
News
DNA Tests now Available Determine Safe Dosage for Dangerous Drugs, Coumadin and Warfarin
The test reveals data from two specific genes that accurately forecast how the patient would respond to Coumadin.
Advertisement
